Whitelogolarge.jpg
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
26 juin 2024 10h00 HE | Monteverde & Associates PC
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
Whitelogolarge.jpg
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
21 juin 2024 11h02 HE | Monteverde & Associates PC
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
Whitelogolarge.jpg
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SQSP, RPHM, SBOW, NX
29 mai 2024 13h29 HE | Monteverde & Associates PC
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...
klaw.png
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
14 mai 2024 15h52 HE | KUEHN LAW, PLLC
Kuehn Law Encourages SQSP, HRT, RPHM, and ALE Investors to Contact Law Firm
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
13 mai 2024 07h35 HE | Reneo Pharmaceuticals, Inc.; OnKure, Inc
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology Combined company is expected to have...
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
07 mai 2024 07h35 HE | Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results